Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) has announced the expansion of its rebranding initiative for the home health division of Kindred at Home (KAH), now transitioning to CenterWell Home Health. This Phase 2 addition includes 14 new states, bringing the total to 21 states involved in the transition. The initiative follows Humana's acquisition of KAH in August 2021 and aims to enhance home-based healthcare services. Phase 3 is set for early September, with operations in an additional 17 states expected to transition, ultimately covering over 350 locations across 38 states.
Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the Jefferies Healthcare Conference on June 8, 2022, at 11:30 a.m. Eastern time. A live audio webcast will be available on Humana's Investor Relations page, with participants advised to log in 15 minutes early for system checks. Humana is dedicated to enhancing health outcomes through integrated care and support for healthcare professionals, focusing on Medicare members and various communities. For more information, visit humana.com.
Humana Inc. (NYSE: HUM) has partnered with Welsh, Carson, Anderson & Stowe to establish a new joint venture, allocating up to
Humana Specialty Pharmacy has been awarded the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category for the fifth consecutive year, highlighting its strong commitment to customer satisfaction and patient care. The award reflects the dedication of its staff, including pharmacists and care coordinators, in providing personalized care. Humana Specialty Pharmacy offers 24-hour access to pharmacists and supports patients applying for assistance programs for specialty drugs. Humana Inc. (NYSE: HUM) aims to improve health outcomes for its members through integrated care solutions.
Humana Inc. (NYSE: HUM) announced that CFO Susan M. Diamond will present at the BofA Securities Healthcare Conference on May 10, 2022, at 9:20 a.m. Pacific time. A live audio webcast will be accessible through Humana’s Investor Relations page, with participants encouraged to log in 15 minutes early for setup. Humana focuses on integrated care to improve health outcomes and lower costs for members, offering services in in-home care, behavioral health, and more. Additional information is available at humana.com.
Humana reported strong 1Q22 earnings with a GAAP EPS of $7.29 and an Adjusted EPS of $8.04, both exceeding previous year figures. The company raised FY 2022 EPS guidance to approximately $22.98 on a GAAP basis and $24.50 on an Adjusted basis, reflecting a 19% growth from FY 2021, despite a COVID-19 headwind. Humana anticipates membership growth of 150,000 to 200,000 in Medicare Advantage for FY 2022 and has introduced a $1 billion value creation initiative to enhance services. Total revenues rose to $23.97 billion from $20.67 billion year-over-year.
Humana Inc. has entered into a definitive agreement to divest a 60% interest in its Hospice and Personal Care divisions of Kindred at Home to Clayton, Dubilier & Rice for approximately $2.8 billion. This transaction reflects a valuation of $3.4 billion and a multiple of about 12 times the divisions’ forecasted Adjusted EBITDA. The move aligns with Humana's strategy to offload non-core segments while still maintaining a minority interest. Proceeds will be used for debt repayment and share repurchases, with no significant impact on 2022 earnings expected.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on July 29, 2022, to stockholders of record as of June 30, 2022. This dividend reflects the company's commitment to providing value to its shareholders while maintaining a robust financial position. Humana focuses on integrated care solutions aimed at improving health outcomes and lowering costs for its members, contributing to a better quality of life for various communities.
Humana Inc. (NYSE: HUM) has released its 2021 Impact Report, underlining its commitment to Environmental, Social, and Governance (ESG) initiatives. The report highlights significant investments, including over $15 million in caregiver support and an 32% increase in primary care centers to 206. Humana conducted 94,000 medical screenings, serving 1.6 million meals to members in need and achieving 16% reduction in greenhouse gas emissions. The company aims to enhance transparency in future ESG reporting as part of its business strategy.
Humana Inc. (NYSE: HUM) announced a new $25 million investment to enhance affordable housing across the United States, raising its total commitment to $50 million. This investment targets various states including Florida, Georgia, and Illinois, aiming to address housing needs for vulnerable communities. Humana's strategy includes interventions to reduce healthcare costs and improve health outcomes. The funds will be deployed through three syndicated funds utilizing low-income housing tax credits to support construction and rehabilitation of affordable housing.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
